Loading clinical trials...
Loading clinical trials...
Patient Preference in Primary Care Depression Treatment
This study will determine the effectiveness of offering primary care patients their preferred treatment versus one that is less desirable in improving treatment adherence and outcome.
This study investigates whether offering primary care patients treatment that is congruent with their preferred first choice improves adherence and outcomes, in comparison to offering treatment that is not congruent with their preferred first choice. All subjects are offered a treatment with demonstrated efficacy, namely either the antidepressant medication escitalopram or Interpersonal Psychotherapy for 5 months. We hypothesize that patients who receive congruent treatment will be more likely to initiate treatment, adhere to treatment, and achieve depression remission.
Age
21 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Cornell Internal Medicine Associates
New York, New York, United States
Weill Medical College of Cornell University
White Plains, New York, United States
Start Date
September 1, 2003
Primary Completion Date
April 1, 2007
Completion Date
May 1, 2007
Last Updated
November 4, 2013
60
Estimated participants
escitalopram
DRUG
interpersonal psychotherapy
BEHAVIORAL
Lead Sponsor
Weill Medical College of Cornell University
Collaborators
NCT04480918
NCT06732284
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06763081